Mark N Lampert
Director, 10% owner, MoonLake Immunotherapeutics
Bought, 12 months
$0.0M
Sold, 12 months
$63.0M
Companies
1
Latest trade
Mar 31, 2026
Companies
MoonLake ImmunotherapeuticsDirector, 10% owner −$63.0M
Trades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.